Nursing for women's health
-
In 2019, the U. S. Food and Drug Administration approved cefiderocol, a new treatment option for individuals with complicated urinary tract infections. ⋯ The recommended dose of cefiderocol is 2 g intravenously every 8 hours infused over 3 hours. The dose is adjusted for individuals with creatinine clearance of less than 60 ml/min or greater than 120 ml/min. Gastrointestinal symptoms such as diarrhea and constipation are the most common adverse events reported by individuals taking cefiderocol.